- Home
- AUPH vs GES Comparison
AUPH vs GES Comparison
Compare AUPH & GES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- GES
- Stock Information
- Founded
- AUPH 1993
- GES 1981
- Country
- AUPH Canada
- GES Switzerland
- Employees
- AUPH N/A
- GES N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- GES Apparel
- Sector
- AUPH Health Care
- GES Consumer Discretionary
- Exchange
- AUPH Nasdaq
- GES Nasdaq
- Market Cap
- AUPH 1.1B
- GES 547.7M
- IPO Year
- AUPH 1999
- GES 1996
- Fundamental
- Price
- AUPH $8.77
- GES $12.04
- Analyst Decision
- AUPH Strong Buy
- GES Buy
- Analyst Count
- AUPH 2
- GES 4
- Target Price
- AUPH $11.50
- GES $17.75
- AVG Volume (30 Days)
- AUPH 1.4M
- GES 896.0K
- Earning Date
- AUPH 07-31-2025
- GES 06-05-2025
- Dividend Yield
- AUPH N/A
- GES 9.98%
- EPS Growth
- AUPH N/A
- GES N/A
- EPS
- AUPH 0.27
- GES 0.10
- Revenue
- AUPH $247,295,000.00
- GES $3,051,131,000.00
- Revenue This Year
- AUPH $12.15
- GES $7.34
- Revenue Next Year
- AUPH $18.31
- GES $3.20
- P/E Ratio
- AUPH $31.76
- GES $124.33
- Revenue Growth
- AUPH 29.20
- GES 9.02
- 52 Week Low
- AUPH $5.20
- GES $8.48
- 52 Week High
- AUPH $10.67
- GES $24.64
- Technical
- Relative Strength Index (RSI)
- AUPH 66.00
- GES 53.52
- Support Level
- AUPH $7.71
- GES $11.81
- Resistance Level
- AUPH $8.29
- GES $12.16
- Average True Range (ATR)
- AUPH 0.25
- GES 0.53
- MACD
- AUPH 0.03
- GES 0.00
- Stochastic Oscillator
- AUPH 84.40
- GES 54.27
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About GES Guess? Inc.
Guess? Inc designs, markets distributes, and licenses contemporary apparel and accessories that reflect European fashion sensibilities and American Lifestyle under brands including Guess, Marciano, and G by Guess. The company has five reportable segments: Americas Retail, Americas Wholesale, Europe, Asia, and licensing. Geographically, the company derives maximum revenue from the United States.